Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 718,400 | 646,100 | 597,600 | 457,000 | 653,800 |
| Marketable Securities | 506,300 | 604,400 | 811,400 | 913,800 | 785,000 |
| Receivables | 371,800 | 338,400 | 351,000 | 345,300 | 325,000 |
| Inventories | 339,900 | 333,500 | 313,300 | 298,500 | 296,800 |
| Income taxes - deferred | N/A | 79,000 | 65,200 | 57,000 | N/A |
| Other current assets | 66,400 | 96,600 | 112,400 | 138,400 | 121,700 |
| TOTAL | $2,047,900 | $2,145,500 | $2,297,000 | $2,254,800 | $2,231,100 |
| Non-Current Assets | |||||
| PPE Net | 482,500 | 454,800 | 450,600 | 445,100 | 442,900 |
| Investments And Advances | 379,900 | 366,000 | 324,600 | 255,600 | 240,900 |
| Intangibles | 833,700 | 828,500 | 389,800 | 388,900 | 399,400 |
| Other Non-Current Assets | 312,300 | 81,800 | 146,300 | 144,000 | 208,700 |
| TOTAL | $2,008,400 | $1,731,100 | $1,311,300 | $1,233,600 | $1,291,900 |
| Total Assets | $4,056,300 | $3,876,600 | $3,608,300 | $3,488,400 | $3,523,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63,900 | 532,500 | 445,200 | 405,300 | 58,200 |
| Accrued Expenses | 412,300 | N/A | N/A | N/A | 367,900 |
| TOTAL | $476,200 | $532,500 | $445,200 | $405,300 | $426,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 596,900 | 604,900 | 600,300 | 602,700 | 598,100 |
| Other Non-Current Liabilities | 480,100 | 317,800 | 274,200 | 266,500 | 307,400 |
| TOTAL | $1,077,000 | $922,700 | $874,500 | $869,200 | $905,500 |
| Total Liabilities | $1,553,200 | $1,455,200 | $1,319,700 | $1,274,500 | $1,331,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 643,793 | 647,129 | 645,094 | 645,346 | 647,040 |
| Common Shares | 239,100 | 130,200 | 129,900 | 129,400 | 128,900 |
| Retained earnings | 3,336,800 | 3,196,100 | 3,078,000 | 2,965,300 | 2,841,900 |
| Other shareholders' equity | -182,600 | -169,200 | -146,400 | -147,800 | -100,800 |
| TOTAL | $2,503,100 | $2,421,400 | $2,288,600 | $2,213,900 | $2,191,400 |
| Total Liabilities And Equity | $4,056,300 | $3,876,600 | $3,608,300 | $3,488,400 | $3,523,000 |